DapE targeting metalloenzyme inhibitors (Loyola University Chicago/AbbVie)

N/A

Report date: 2025/03/18 18:14:44
NME

Base Information

Drug NameDapE targeting metalloenzyme inhibitors (Loyola University Chicago/AbbVie)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLoyola University
China Registration ClassN/A

Develop Information

Active CompaniesLoyola UniversityAbbvie Inc
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A